ReShape Lifesciences
RSLS
trading on NASDAQ
since 2021
$4.85
(Δ -0.78%)
-$0.04 since open
ReShape Lifesciences develops medical devices for obesity treatment, including the ReShape gastric band, a minimally invasive solution that adjusts to help manage weight.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.72 | $4.88 | $4.52 | $3.38M | 134.31K |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| +$18.98 | 0.31 | 0.34 | -198.20% | 132.43% | 0% |